DNMT1 and Huntington disease: The potential therapeutical importance of epigenetic effects in HD pathology is underlined by studies showing that symptoms can be mitigated by histone deacetylase (HDAC), histone demethylase, and DNA methyltransferase (DNMT) inhibitors in HD models [12,13,14].